A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

NCT ID: NCT06087640

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

35800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-23

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Phase 3 study is a randomized, observer-blind study of MF59-adjuvanted influenza vaccine (aQIV or aTIV) compared with a non-adjuvanted influenza vaccine (QIV or TIV) in adults ≥65 years of age. The aim of the study is to evaluate MF59-adjuvanted influenza vaccine compared with non-adjuvanted influenza vaccine in the prevention of reverse transcription-polymerase chain reaction (RT-PCR)-confirmed influenza A and/or B in subjects ≥65 years of age.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza, Human

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MF59-adjuvanted influenza vaccine

MF59-adjuvanted QIV containing 2 influenza type A strains and 2 influenza type B strains or MF59-adjuvanted TIV containing 2 influenza type A strains and 1 influenza type B strain

Group Type EXPERIMENTAL

aQIV or aTIV

Intervention Type BIOLOGICAL

Participants receive a 0.5-mL intramuscular dose of aQIV or aTIV on Day 1. A 0.5 mL dose of aQIV contains nominally 15 µg of hemagglutinin (HA) of each of the 2 influenza type A strains and each of the 2 influenza B strains (total of 60 µg HA). A 0.5 mL dose of aTIV contains nominally 15 µg of HA of each of the 2 influenza type A strains and of the influenza B strain (total of 45 µg HA). The strain composition of aQIV and aTIV is that recommended by the World Health Organization (WHO) for quadrivalent and trivalent influenza vaccines, respectively, contemporaneous to the timing of the study.

Non-adjuvanted influenza vaccine

Non-adjuvanted QIV containing 2 influenza type A strains and 2 influenza type B strains or Non-adjuvanted TIV containing 2 influenza type A strains and 1 influenza type B strain

Group Type OTHER

QIV or TIV

Intervention Type BIOLOGICAL

Participants receive a 0.5-mL intramuscular dose of the non-adjuvanted QIV or TIV on Day 1. A 0.5 mL dose of QIV contains nominally 15 μg of HA of each of the 2 influenza type A strains and each of the 2 influenza B strains (total of 60 μg HA). A 0.5 mL dose of TIV contains nominally 15 μg of HA of each of the 2 influenza type A strains and of the influenza B strain (total of 45 μg HA). The strain composition of QIV and TIV is that recommended by the WHO for quadrivalent and trivalent influenza vaccines, respectively, contemporaneous to the timing of the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

aQIV or aTIV

Participants receive a 0.5-mL intramuscular dose of aQIV or aTIV on Day 1. A 0.5 mL dose of aQIV contains nominally 15 µg of hemagglutinin (HA) of each of the 2 influenza type A strains and each of the 2 influenza B strains (total of 60 µg HA). A 0.5 mL dose of aTIV contains nominally 15 µg of HA of each of the 2 influenza type A strains and of the influenza B strain (total of 45 µg HA). The strain composition of aQIV and aTIV is that recommended by the World Health Organization (WHO) for quadrivalent and trivalent influenza vaccines, respectively, contemporaneous to the timing of the study.

Intervention Type BIOLOGICAL

QIV or TIV

Participants receive a 0.5-mL intramuscular dose of the non-adjuvanted QIV or TIV on Day 1. A 0.5 mL dose of QIV contains nominally 15 μg of HA of each of the 2 influenza type A strains and each of the 2 influenza B strains (total of 60 μg HA). A 0.5 mL dose of TIV contains nominally 15 μg of HA of each of the 2 influenza type A strains and of the influenza B strain (total of 45 μg HA). The strain composition of QIV and TIV is that recommended by the WHO for quadrivalent and trivalent influenza vaccines, respectively, contemporaneous to the timing of the study.

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Fluad Tetra/Quadrivalent or Fluad

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults of ≥65 years of age on the day of vaccination.
2. Individuals who have voluntarily given written informed consent after the nature of the study has been explained according to local regulatory requirements, prior to study entry.
3. Individuals who have the ability to comply with study procedures including follow-up.

Exclusion Criteria

1. Bedridden subjects (i.e. confined to bed by sickness or old age).
2. Subjects that are incapacitated and because of that in need of a Legally Authorized Representative.
3. Receipt of any influenza vaccine within 6 months prior to enrollment or any plan to receive influenza vaccine while participating in the study.
4. Hypersensitivity, including allergy, to any component of vaccines whose use is foreseen in this study, or severe allergic reaction (e.g. anaphylaxis) to previous influenza vaccination.
5. Known history of Guillain-Barré syndrome or another demyelinating disease such as encephalomyelitis and transverse myelitis.
6. Clinical conditions representing a contra-indication to intramuscular administration of vaccines or blood draw.
7. Abnormal function of the immune system resulting from:

1. Clinical conditions;
2. Systemic administration of corticosteroids (PO/IV/IM) at a dose ≥20 mg/day of prednisone (or equivalent) for more than 14 consecutive days within 90 days prior to informed consent; Topical, inhaled and intranasal corticosteroids are permitted. Intermittent use (one dose in 30 days) of intra-articular corticosteroids are also permitted;
3. Administration of antineoplastic and immunomodulating agents or radiotherapy within 90 days prior to informed consent.
8. Receipt of immunoglobulins or any blood products within 180 days prior to informed consent.
9. Receipt of any investigational or non-registered product (drug or vaccine) other than the study vaccine within 30 days preceding the study vaccination, or planned use during the entire study period.
10. Acute (severe) febrile illness.
11. Any other clinical condition that, in the opinion of the investigator, might interfere with the results of the study or pose additional risk to the subject due to participation in the study.
12. Study personnel or immediate family members (brother, sister, child, parent) or the spouse of study personnel.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seqirus

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Program Director

Role: STUDY_DIRECTOR

Seqirus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

84046-Accel Research Sites - Birmingham

Birmingham, Alabama, United States

Site Status

84075-Cullman Clinical Trials

Cullman, Alabama, United States

Site Status

84112-DM Clinical Research - Phoenix

Phoenix, Arizona, United States

Site Status

84114-Scottsdale Clinical Trials

Scottsdale, Arizona, United States

Site Status

84045-Lynn Institute of the Ozarks

Little Rock, Arkansas, United States

Site Status

84070-Baptist Health Center for Clinical Research

Little Rock, Arkansas, United States

Site Status

84101-West Coast Research LLC

Dublin, California, United States

Site Status

84124-Leading Edge Research

Encino, California, United States

Site Status

84104-Zillan Clinical Research

Inglewood, California, United States

Site Status

84105-Eximia Research - CA

La Mesa, California, United States

Site Status

84107-Long Beach Research Institute

Long Beach, California, United States

Site Status

84109-Long Beach Clinical Trials

Long Beach, California, United States

Site Status

84115-Central Valley Research

Modesto, California, United States

Site Status

84120-Paradigm Research

Redding, California, United States

Site Status

84119-Apex Clinical Research

San Diego, California, United States

Site Status

84125-Lynn Institute of Denver

Aurora, Colorado, United States

Site Status

84110-Tekton Research

Longmont, Colorado, United States

Site Status

84123-Paradigm Research

Wheat Ridge, Colorado, United States

Site Status

84085-Clinical Research Consulting, LLC

Milford, Connecticut, United States

Site Status

84017-Chase Medical Research, LLC

Waterbury, Connecticut, United States

Site Status

84029-Imagine Research of Palm Beach County

Boynton Beach, Florida, United States

Site Status

84067-Innovative Research of West Florida, Inc.

Clearwater, Florida, United States

Site Status

84006-Nature Coast Clinical Research - Crystal River

Crystal River, Florida, United States

Site Status

84012-Evolution Clinical Trials

Doral, Florida, United States

Site Status

84016-USA and International Research Inc.

Doral, Florida, United States

Site Status

84061-Velocity Clinical Research - New Smyrna Beach

Edgewater, Florida, United States

Site Status

84065-Fleming Island Center for Clinical Research

Fleming Island, Florida, United States

Site Status

84027-SIMEDHealth, LLC

Gainesville, Florida, United States

Site Status

84019-Green Leaf Clinical Trials

Jacksonville, Florida, United States

Site Status

84026-Health Awareness, Inc.

Jupiter, Florida, United States

Site Status

84071-3SYNC Research

Lake Worth, Florida, United States

Site Status

84083-Accel Research Sites Network - St. Petersburg-Largo

Largo, Florida, United States

Site Status

84082-Global Health Research Center, Inc.

Miami Lakes, Florida, United States

Site Status

84081-Suncoast Research Associates, LLC

Pembroke Pines, Florida, United States

Site Status

84024-St. Johns Center for Clinical Research

Saint Augustine, Florida, United States

Site Status

84051-Precision Clinical Research

Sunrise, Florida, United States

Site Status

84008-Global Health Research Center, Inc. - Tampa

Tampa, Florida, United States

Site Status

84037-Eximia Research - GA

Atlanta, Georgia, United States

Site Status

84086-Agile Clinical Research Trials, LLC

Atlanta, Georgia, United States

Site Status

84054-Centricity Research Columbus

Columbus, Georgia, United States

Site Status

84013-M3 Wake Research/Mount Vernon Clinical Research, LLC

Sandy Springs, Georgia, United States

Site Status

84069-Velocity Clinical Research - Savannah

Savannah, Georgia, United States

Site Status

84039-North Georgia Clinical Research

Woodstock, Georgia, United States

Site Status

84118-Velocity Clinical Research - Boise

Meridian, Idaho, United States

Site Status

84060-Great Lakes Clinical Trials LLC, dba Flourish Research

Chicago, Illinois, United States

Site Status

84022-DM Clinical Research - River Forest

Melrose Park, Illinois, United States

Site Status

84025-Velocity Clinical Research - Valparaiso

Valparaiso, Indiana, United States

Site Status

84042-Velocity Clinical Research - Sioux City

Sioux City, Iowa, United States

Site Status

84055-Velocity Clinical Research - Baton Rouge

Baton Rouge, Louisiana, United States

Site Status

84088-Velocity Clinical Research - Covington

Covington, Louisiana, United States

Site Status

84052-Velocity Clinical Research - Lafayette

Lafayette, Louisiana, United States

Site Status

84064-Benchmark Research

Metairie, Louisiana, United States

Site Status

84005-DM Clinical Research - Brookline

Brookline, Massachusetts, United States

Site Status

84002-ActivMed Practices and Research, LLC

Methuen, Massachusetts, United States

Site Status

84044-Clarkston Medical Group

Clarkston, Michigan, United States

Site Status

84018-Quest Research Institute

Farmington Hills, Michigan, United States

Site Status

84032-Bioscope Clinical Research, LLC

Farmington Hills, Michigan, United States

Site Status

84001-Revival Research Institute, LLC

Southfield, Michigan, United States

Site Status

84074-DM Clinical Research - Southfield

Southfield, Michigan, United States

Site Status

84023-Velocity Clinical Research - Gulfport

Gulfport, Mississippi, United States

Site Status

84038-Kansas City Research Institute

Kansas City, Missouri, United States

Site Status

84057-Sundance Clinical Research

St Louis, Missouri, United States

Site Status

84108-Boeson Research MSO

Missoula, Montana, United States

Site Status

84030-Velocity Clinical Research - Grand Island

Grand Island, Nebraska, United States

Site Status

84040-Velocity Clinical Research - Norfolk

Norfolk, Nebraska, United States

Site Status

84007-Velocity Clinical Research - Omaha

Omaha, Nebraska, United States

Site Status

84117-M3 Wake Research/CRCN

Las Vegas, Nevada, United States

Site Status

84103-Alliance for Multispecialty Research, LLC

Las Vegas, Nevada, United States

Site Status

84111-Vector Clinical Trials

Las Vegas, Nevada, United States

Site Status

84106-Las Vegas Clinical Trials

North Las Vegas, Nevada, United States

Site Status

84003-DM Clinical Research - New Jersey

Jersey City, New Jersey, United States

Site Status

84122-Albuquerque Clinical Trials

Albuquerque, New Mexico, United States

Site Status

84048-Velocity Clinical Research - Binghamton

Binghamton, New York, United States

Site Status

84077-Velocity Clinical Research - Syracuse

East Syracuse, New York, United States

Site Status

84014-Asheville Clinical Research

Asheville, North Carolina, United States

Site Status

84089-Velocity Clinical Research - Durham

Durham, North Carolina, United States

Site Status

84035-Monroe Biomedical Research

Monroe, North Carolina, United States

Site Status

84102-Eximia Research - NC

Raleigh, North Carolina, United States

Site Status

84020-M3 Wake Research/Raleigh Clinical Research, LLC

Raleigh, North Carolina, United States

Site Status

84004-TMA Headlands LLC, dba Trial Management Associates

Wilmington, North Carolina, United States

Site Status

84079-Progressive Medicine of the Triad, LLC

Winston-Salem, North Carolina, United States

Site Status

84021-Velocity Clinical Research - Cleveland

Beachwood, Ohio, United States

Site Status

84034-CTI Clinical Research Center

Cincinnati, Ohio, United States

Site Status

84063-Velocity Clinical Research - Cincinnati (Mt. Auburn)

Cincinnati, Ohio, United States

Site Status

84078-Tekton Research

Yukon, Oklahoma, United States

Site Status

84121-Velocity Clinical Research - Medford

Medford, Oregon, United States

Site Status

84050-3SYNC Research

Pittsburgh, Pennsylvania, United States

Site Status

84009-Velocity Clinical Research - Providence

East Greenwich, Rhode Island, United States

Site Status

84010-M3 Wake Research/Charleston Clinical Trials, LLC

Charleston, South Carolina, United States

Site Status

84043-Velocity Clinical Research - Gaffney

Gaffney, South Carolina, United States

Site Status

84056-Coastal Carolina Research Center, LLC

North Charleston, South Carolina, United States

Site Status

84047-Velocity Clinical Research - Spartanburg

Spartanburg, South Carolina, United States

Site Status

84053-Velocity Clinical Research - Union

Union, South Carolina, United States

Site Status

84068-WR-ClinSearch, LLC

Chattanooga, Tennessee, United States

Site Status

84090-Alliance for Multispecialty Research, LLC

Knoxville, Tennessee, United States

Site Status

84084-Clinical Research Associates, Inc.

Nashville, Tennessee, United States

Site Status

84072-WR-Global Medical Research, LLC

Dallas, Texas, United States

Site Status

84028-Benchmark Research

Fort Worth, Texas, United States

Site Status

84015-Trio Clinical Trials LLC

Houston, Texas, United States

Site Status

84062-Activian Clinical Research

Kingwood, Texas, United States

Site Status

84080-ACRC Trials

Plano, Texas, United States

Site Status

84031-North Texas Family Medicine

Plano, Texas, United States

Site Status

84066-Research Your Health

Plano, Texas, United States

Site Status

84011-Clinical Trials of Texas, LLC, dba Flourish Research

San Antonio, Texas, United States

Site Status

84076-DM Clinical Research - San Antonio

San Antonio, Texas, United States

Site Status

84059-DM Clinical Research - Sugar Land

Sugar Land, Texas, United States

Site Status

84087-DM Clinical Research - Tomball

Tomball, Texas, United States

Site Status

84049-Charlottesville Medical Research

Charlottesville, Virginia, United States

Site Status

84058-Clinical Research Partners

Richmond, Virginia, United States

Site Status

84036-Velocity Clinical Research - Suffolk

Suffolk, Virginia, United States

Site Status

84113-DM Clinical Research - Seattle

Seattle, Washington, United States

Site Status

03603-University of the Sunshine Coast

Birtinya, , Australia

Site Status

03609-Paratus Clinical Western Sydney

Blacktown, , Australia

Site Status

03605-Emeritus Research - Sydney

Botany, , Australia

Site Status

03614-Northern Beaches Clinical Research

Brookvale, , Australia

Site Status

03602-Emeritus Research - Melbourne

Camberwell, , Australia

Site Status

03615-Momentum Clinical Research Darlinghurst

Darlinghurst, , Australia

Site Status

03608-Paratus Clinical Brisbane

Herston, , Australia

Site Status

03610-Paratus Clinical Central Coast

Kanwal, , Australia

Site Status

03604-Doherty Clinical Trials Limited

Melbourne, , Australia

Site Status

03611-Nucleus Network

Melbourne, , Australia

Site Status

03601-University of the Sunshine Coast - Morayfield

Morayfield, , Australia

Site Status

03607-University of the Sunshine Coast - South Bank

South Brisbane, , Australia

Site Status

03613-Momentum Clinical Research Taringa

Taringa, , Australia

Site Status

03612-Wollongong Clinical Reserach

Wollongong, , Australia

Site Status

05605-AZ Sint-Jan Brugge-Oostende - Campus Sint-Jan

Bruges, , Belgium

Site Status

05602-Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

05603-Medif BVBA

Gozée, , Belgium

Site Status

05601-Jan Yperman Ziekenhuis

Ieper, , Belgium

Site Status

10005-MHAT Dr. Tota Venkova

Gabrovo, , Bulgaria

Site Status

10018-Medical Center - Zdrave-1

Kozloduy, , Bulgaria

Site Status

10029-Medical Centre Leo Clinic EOOD

Lovech, , Bulgaria

Site Status

10007-Medical Center Hera EOOD

Montana, , Bulgaria

Site Status

10014-Multi-Profile Hospital For Active Treatment Dr. Stamen Iliev AD

Montana, , Bulgaria

Site Status

10032-MHAT Zdrave

Pazardzhik, , Bulgaria

Site Status

10019-MC Med Consult Pleven

Pleven, , Bulgaria

Site Status

10022-Ambulatory Outpatient Medical Practice for First Patient Care Zaprin Pepelov

Plovdiv, , Bulgaria

Site Status

10024-UMHAT Pulmed

Plovdiv, , Bulgaria

Site Status

10026-Multiprofile Hospital for Active Treatment Sv. Panteleymon - Plovdiv

Plovdiv, , Bulgaria

Site Status

10031-Medical Centre Pratia Clinic EOOD

Plovdiv, , Bulgaria

Site Status

10004-Medical Center Prolet EOOD

Rousse, , Bulgaria

Site Status

10012-Specialized Hospital For Active Treatment Of Pneumo-Phthisiatric Diseases Dr. Dimitar Gramatikov-Ruse EOOD

Rousse, , Bulgaria

Site Status

10016-Medical Center 1 - Sevlievo EOOD

Sevlievo, , Bulgaria

Site Status

10023-DCC-1 Sliven

Sliven, , Bulgaria

Site Status

10006-DCC 22 - Sofia

Sofia, , Bulgaria

Site Status

10015-Medical Center Hera - Pulmonology Office

Sofia, , Bulgaria

Site Status

10021-Medical Center Intermedica

Sofia, , Bulgaria

Site Status

10028-Medical Center Excelsior OOD

Sofia, , Bulgaria

Site Status

10030-Diagnostic-Consultative Centre Ascendent EOOD

Sofia, , Bulgaria

Site Status

10027-AIPPMP D-r Zhaneta Demireva

Stamboliyski, , Bulgaria

Site Status

20307-CCR Brno s.r.o.

Brno, , Czechia

Site Status

20305-Centrum ockovani a cestovni mediciny

České Budějovice, , Czechia

Site Status

20306-ADMED, s.r.o.

České Budějovice, , Czechia

Site Status

20311-Ordinace Hradebni s.r.o

České Budějovice, , Czechia

Site Status

20310-MUDr. Jakub Strincl, s.r.o.

Liberec, , Czechia

Site Status

20309-CCR Ostrava, s.r.o.

Ostrava, , Czechia

Site Status

20308-MUDr. Jakub Strincl, s.r.o.

Protivín, , Czechia

Site Status

20312-MEDISON s.r.o.

Přeštice, , Czechia

Site Status

24603-Helsinki South Vaccine Research Clinic

Helsinki, , Finland

Site Status

24602-Oulu Vaccine Research Clinic

Oulu, , Finland

Site Status

24601-Tampere Vaccine Research Clinic

Tampere, , Finland

Site Status

24604-Turku Vaccine Research Clinic

Turku, , Finland

Site Status

26803-UNIMED Adjara LTD - Batumi Referral Hospital

Batumi, , Georgia

Site Status

26801-LTD Hospital Service

Kutaisi, , Georgia

Site Status

26802-Acad. G. Chapidze Emergency Cardiology Center

Tbilisi, , Georgia

Site Status

26804-K. Eristavi National Center of Clinical Surgery

Tbilisi, , Georgia

Site Status

38003-Policlinico Bari

Bari, , Italy

Site Status

38001-PO A. Manzoni di Lecco, ASST Lecco

Lecco, , Italy

Site Status

38004-Ospedale Fatebenefratelli e Oftalmico, ASST Fatebenefratelli Sacco

Milan, , Italy

Site Status

44004-JSC InMedica

Kaunas, , Lithuania

Site Status

44008-JSC Saulės Šeimos Medicinos Centras

Kaunas, , Lithuania

Site Status

44009-Hospital of Lithuanian University of Health Sciences Kauno klinikos

Kaunas, , Lithuania

Site Status

44010-InlitaJSC Santara CTC

Vilnius, , Lithuania

Site Status

52802-Emotional Brain BV

Almere Stad, , Netherlands

Site Status

52804-Universitair Medisch Centrum (UMC) Utrecht - Julius Center for Health Sciences and Primary Care

Utrecht, , Netherlands

Site Status

55404-Optimal Clinical Trials - Central

Grafton, , New Zealand

Site Status

55402-Momentum Clinical Research Wellington

Mount Cook, , New Zealand

Site Status

55405-Pacific Clinical Research Network - West Auckland

New Lynn, , New Zealand

Site Status

55403-Optimal Clinical Trials - North

Rosedale, , New Zealand

Site Status

55401-PCRN - Auckland

Takapuna, , New Zealand

Site Status

60812-Health Index Multispecialty and Lying-In Clinic

Bacoor, , Philippines

Site Status

60813-Norzel Medical and Diagnostic Clinic

Cebu, , Philippines

Site Status

60808-CT CARE Group

Dasmariñas, , Philippines

Site Status

60801-Davao Doctors Hospital

Davao City, , Philippines

Site Status

60802-West Visayas State University Medical Center

Iloilo City, , Philippines

Site Status

60815-St Paul's Hospital Iloilo

Iloilo City, , Philippines

Site Status

60816-St Paul's Hospital Iloilo

Iloilo City, , Philippines

Site Status

60803-Philippine General Hospital

Manila, , Philippines

Site Status

60811-Philippine General Hospital

Manila, , Philippines

Site Status

60814-Manila Doctors Hospital

Manila, , Philippines

Site Status

60804-St. Michael Family Hospital

Marilao, , Philippines

Site Status

60805-San Juan de Dios Hospital

Pasay, , Philippines

Site Status

60806-Quirino Memorial Medical Center

Quezon City, , Philippines

Site Status

60817-Silang Specialist Medical Center

Silang, , Philippines

Site Status

61619-Krakowskie Centrum Medyczne Sp. z o.o

Krakow, , Poland

Site Status

61618-Centrum Medyczne AMED Oddzial w Lodzi

Lodz, , Poland

Site Status

61622-KOMED Nova Lublin II

Lublin, , Poland

Site Status

61620-KOMED Nova Pulawy

Puławy, , Poland

Site Status

61614-KO-MED Centra Kliniczne Staszow

Staszów, , Poland

Site Status

61605-RCMed Oddział Warszawa

Warsaw, , Poland

Site Status

61615-ETG Warszawa

Warsaw, , Poland

Site Status

61616-MTZ Clinical Research

Warsaw, , Poland

Site Status

61621-Futuremed Warszawa Centrum

Warsaw, , Poland

Site Status

61617-Przychodnia FutureMeds Wroclaw

Wroclaw, , Poland

Site Status

61623-KOMED Nova Zamosc

Zamość, , Poland

Site Status

64210-Sana Monitoring

Bucharest, , Romania

Site Status

64208-Spitalul Municipal Caracal

Caracal, , Romania

Site Status

64204-Ames Research Center

Călăraşi, , Romania

Site Status

64209-Clintrial Medical Center

Reșca, , Romania

Site Status

64211-Nova-Clin Medical Research Center

Timișoara, , Romania

Site Status

68803-Clinical Center of Serbia

Belgrade, , Serbia

Site Status

68805-Clinical Hospital Center Zemun

Belgrade, , Serbia

Site Status

68806-CHC Bezanijska Kosa

Belgrade, , Serbia

Site Status

68802-Institute for Pulmonary Disease of Vojvodina

Kamenitz, , Serbia

Site Status

68804-General Hospital Valjevo

Valjevo, , Serbia

Site Status

71007-Josha Research Center

Bloemfontein, , South Africa

Site Status

71008-Madibeng Centre for Research

Brits, , South Africa

Site Status

71011-University of Cape Town Lung Institute

Cape Town, , South Africa

Site Status

71014-TREAD Research

Cape Town, , South Africa

Site Status

71015-Tiervlei Trial Centre

Cape Town, , South Africa

Site Status

71001-Ubuntu Clinical Research Krugersdorp

Krugersdorp, , South Africa

Site Status

71010-Merclinico Middelburg

Middelburg, , South Africa

Site Status

71009-Newtown Clinical Research Centre

Newtown, , South Africa

Site Status

71005-Be Part Research

Paarl, , South Africa

Site Status

71013-Into Research, Life Groenkloof Hospital

Pretoria, , South Africa

Site Status

71003-Tsitsikamma Clinical Research Initiative

Thabazimbi, , South Africa

Site Status

71004-FCRN Clinical Trials Centre

Vereeniging, , South Africa

Site Status

41002-Korea University Ansan Hospital

Ansan, , South Korea

Site Status

41001-Inha University Hospital

Incheon, , South Korea

Site Status

41004-Hallym University Kangnam Sacred Heart Hospital

Seoul, , South Korea

Site Status

41005-Korea University Guro Hospital

Seoul, , South Korea

Site Status

41003-Ajou University Hospital

Suwon, , South Korea

Site Status

72402-EAP Vic - CAP El Remei

Barcelona, , Spain

Site Status

72407-Futurmeds Spain Cadiz

Cadiz, , Spain

Site Status

72405-Futuremeds Spain Madrid

Madrid, , Spain

Site Status

72404-Hospital Universitario Son Espases

Palma de Mallorca, , Spain

Site Status

72403-Complexo Hospitalario Universitario De Santiago

Santiago de Compostela, , Spain

Site Status

72406-Futuremeds Spain Sevilla

Seville, , Spain

Site Status

72401-Hospital Povisa

Vigo, , Spain

Site Status

15803-Taipei Medical University - Shuang Ho Hospital

New Taipei City, , Taiwan

Site Status

15801-China Medical University Hospital

Taichung, , Taiwan

Site Status

15802-National Cheng Kung University Hospital

Tainan, , Taiwan

Site Status

15804-Taipei Medical University - Wanfang Hospital

Taipei, , Taiwan

Site Status

15805-Taipei Medical University

Taipei, , Taiwan

Site Status

79209-Hacettepe University Faculty of Medicine

Ankara, , Turkey (Türkiye)

Site Status

79207-Akdeniz University Faculty of Medicine

Antalya, , Turkey (Türkiye)

Site Status

79212-Dicle Universitesi Tip Fakultesi

Diyarbakır, , Turkey (Türkiye)

Site Status

79205-Goztepe Suleyman Yalcin City Hospital

Istanbul, , Turkey (Türkiye)

Site Status

791210-Dokuz Eylul University Faculty of Medicine

Izmir, , Turkey (Türkiye)

Site Status

79208-Izmir Dr. Suat Seren Pulmonary Hospital

Izmir, , Turkey (Türkiye)

Site Status

79213-Ege University Hospital

Izmir, , Turkey (Türkiye)

Site Status

79204 - Kocaeli University Faculty of Medicine

Kocaeli, , Turkey (Türkiye)

Site Status

79211-Karadeniz Technical University Faculty of Medicine

Trabzon, , Turkey (Türkiye)

Site Status

71601-Charles River Medical Group, Mutala Trust and Infectious Disease Research Laboratory

Harare, , Zimbabwe

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Belgium Bulgaria Czechia Finland Georgia Italy Lithuania Netherlands New Zealand Philippines Poland Romania Serbia South Africa South Korea Spain Taiwan Turkey (Türkiye) Zimbabwe

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

V118_24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.